key: cord-0717695-bkzassy7
authors: La Malfa, Giovanni; Spallarossa, Paolo; Tini, Giacomo; Sarocchi, Matteo; Salsano, Antonio; Parolari, Giulia; Guadagno, Antonio; Sciallero, Stefania; Porto, Italo; Santini, Francesco
title: Cancer Patient With Unusual Dyspnea in the COVID-19 Era: Challenging Management of a Rare Cardiac Tumor
date: 2021-03-10
journal: JACC Case Rep
DOI: 10.1016/j.jaccas.2021.01.011
sha: ca63263b3d6f8d0197ad27fb97a85dd464319772
doc_id: 717695
cord_uid: bkzassy7

Heart failure symptoms, in particular dyspnea, may be difficult to frame in a patient with cancer. We report the case of an oncological patient whose dyspnea could have been attributable to various causes and whose management was challenging in the context of the coronavirus disease-2019 pandemic. (Level of Difficulty: Beginner.)

To consider intracardiac tumors in the differential diagnosis of patients with dyspnea and a history of cancer from other sites, to avoid potentially fatal diagnostic delays. To understand the importance of echocardiography in the diagnosis of intracardiac tumors, as noncontrast CT imaging could fail to detect them. To remark the importance of a careful clinical examination, even in this uneasy pandemic era.

the patient to our Cardio-Oncology outpatient clinics the same day.

At our examination, the patient was completely asymptomatic at rest, showing lack of change in symptoms with postural modifications but reported severe dyspnea and episodes of dizziness with minimal efforts. Cardiac auscultation revealed a 4/6 harsh systolic murmur in the parasternal region. His lung examination was unrevealing.

There was no evidence of peripheral swelling.

The patient was obese and an ex-smoker with a history of MPNST. The MPNST had first been diagnosed and surgically resected from the left popliteal fossa w4 years earlier.

Surgery was followed by radiotherapy and first-line chemotherapy with epidoxorubicin (4 cycles for a total dose of 140 mg/m 2 , the last administered 37 months before) and ifosphamide. In the last 2 years, the patient had undergone surgery 3 other times for resection of recurrences, the first located at the inguinal region and the last 2 at the scalp. In accordance with previous histological examination, the surgical specimens confirmed MPNST with disease-free resection margins.

The differential diagnosis included: recurrence of oncological disease; cancer therapeutics-related cardiac dysfunction; pulmonary embolism; an infectious or inflammatory process, including COVID-19; and ischemic heart disease. 

The patient's dyspnea rapidly improved and N-terminal pro-B-type natriuretic peptide values decreased to 

The authors have reported that they have no relationships relevant to the contents of this paper to disclose. 

Malignant peripheral nerve sheath tumor

Malignant peripheral nerve sheath tumor of the heart

Neurogenic sarcoma in the heart

Primary cardiac malignant peripheral nerve sheath tumor: a case report

Atypical presentation of a primary cardiac malignant peripheral nerve sheath tumor

Malignant neurogenic tumor of the heart